Tempus Ai (TEM) Stock
Enterprise AI platform helping businesses analyze complex data. Here's the price, business snapshot, and what's worth knowing about Tempus Ai in July 2026.
Tempus AI (TEM) is a publicly traded technology company focused on developing artificial intelligence platforms and services that help organisations extract insights from large, complex datasets. With a market capitalisation of about $15.48 billion, it sits in the growth-tech segment and attracts investors seeking exposure to AI-driven enterprise software. Key investor considerations include revenue growth, customer adoption, recurring revenue trends and ongoing investments in model development, data partnerships and cloud infrastructure. As a growth company, Tempus AI may trade at a premium to near‑term earnings, making its share price sensitive to execution, guidance and broader market sentiment. Risks include competition from major cloud and software vendors, the need for sustained R&D spending, data privacy and regulatory changes, and potential swings in enterprise IT budgets. This summary is for educational purposes only and is not personalised financial advice; investors should review the company’s filings and assess whether this stock fits their risk tolerance and time horizon.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying TEMPUS AI's stock with a target price of $87.92, indicating strong growth potential.
Financial Health
TEMPUS AI is performing well with strong revenue, cash flow, and profit margins, indicating good financial health.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring TEM
Singapore Applied AI Hub Stocks to Watch in 2026
OpenAI has signed its first government MOU to establish an applied AI lab in Singapore, committing over S$300 million to build the city-state into a global hub for real-world AI deployment. This partnership opens the door for companies across enterprise AI software, cloud infrastructure, healthcare AI, and workforce development to expand their footprint across Southeast Asia.
Published: 20 May 2026
Explore BasketAI-Driven Pharma Stocks | Pipeline Innovation
Novo Nordisk's partnership with OpenAI highlights a massive shift as major drugmakers integrate generative AI into their core operations. This basket captures the pharmaceutical giants optimizing their pipelines alongside the tech titans providing the underlying AI infrastructure.
Published: 15 April 2026
Explore BasketCould Warsh's Fed Shift Fuel AI & Rate-Sensitive Stocks?
The nomination of Kevin Warsh as Federal Reserve Chair signals a potential shift toward lower interest rates driven by his belief in AI-fueled productivity. This basket highlights companies in rate-sensitive and high-growth sectors poised to benefit from cheaper borrowing costs.
Published: 5 March 2026
Explore BasketAlphabet AI Stocks | $4 Trillion Market Cap Impact
Alphabet's achievement of a $4 trillion market cap, driven by its AI leadership and a new partnership with Apple, signals an escalation in the tech industry's AI arms race. This creates a compelling investment opportunity in the network of companies, from hardware suppliers to software developers, that support and benefit from its expanding AI ecosystem.
Published: 18 January 2026
Explore BasketAI Drug Discovery | Biotech Investment Opportunities
NVIDIA and Eli Lilly have launched a $1 billion AI lab to revolutionize the drug discovery process. This partnership highlights a burgeoning investment opportunity in companies at the intersection of artificial intelligence and biotechnology.
Published: 13 January 2026
Explore BasketAI World Models: Risks in Next-Gen Tech Investing
Yann LeCun, a key figure in AI, has left Meta to launch a startup focused on 'world models,' a new frontier in artificial intelligence. This move highlights a potential investment opportunity in companies pioneering next-generation AI research and the infrastructure that supports it.
Published: 20 November 2025
Explore BasketTech Stocks (AI Valuation Reset) Present Potential Entry
Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.
Published: 17 November 2025
Explore BasketAI Data Stocks (Post-Palantir Earnings Surge)
Palantir's exceptional earnings, fueled by its AI platform, highlight a massive market expansion for data analytics. This trend suggests a significant growth opportunity for other companies operating within the broader AI and data infrastructure ecosystem.
Published: 4 November 2025
Explore BasketNvidia Intel Partnership: Beyond the $5B Deal
Nvidia announced a $5 billion investment in Intel, marking a significant partnership between the two semiconductor rivals to jointly develop AI-focused chips. This collaboration could create opportunities for other companies in the semiconductor supply chain and AI software development.
Published: 19 September 2025
Explore BasketUS-UK Tech Alliance | Nvidia CEO Joins Diplomatic Trip
Nvidia's CEO is joining a diplomatic trip to the UK, signaling a new era of corporate-led efforts to boost transatlantic technology partnerships. This initiative is expected to drive investment into AI, semiconductor, and energy companies in both the US and the UK.
Published: 9 September 2025
Explore BasketPerformance-Linked AI Leadership Explained
Tesla's proposal of a massive, performance-linked pay package for Elon Musk highlights its aggressive growth strategy. This move, which also involves investment in Musk's xAI, creates an investment theme centered on companies that tie executive incentives to ambitious innovation and AI expansion.
Published: 8 September 2025
Explore BasketMobile AI's Antitrust Challenge
Elon Musk's companies are suing Apple and OpenAI, alleging their partnership creates an anti-competitive monopoly in the AI space. This legal battle could unlock the mobile AI market for competitors, creating a significant growth opportunity for other AI technology firms.
Published: 27 August 2025
Explore BasketAI Talent Market Shifts: Tech Stocks to Watch 2025
Meta has frozen hiring in its AI division, creating a potential shift in the highly competitive talent market. This presents an opportunity for other major tech firms to attract top researchers and engineers who are now available.
Published: 22 August 2025
Explore BasketPowering the AI Revolution: OpenAI's Valuation Catalyst
OpenAI's recent employee stock sale has launched its valuation to an estimated $500 billion, backed by major investors like SoftBank. This event signals a massive acceleration in AI development, creating potential opportunities for companies that provide the critical infrastructure and technology powering this growth.
Published: 18 August 2025
Explore BasketHealthcare's Compliance Catalyst
The Department of Justice's investigation into UnitedHealth's billing practices is increasing pressure on the entire healthcare industry to ensure compliance. This regulatory focus creates an investment opportunity in companies that provide specialized technology for transparent and accurate medical billing.
Published: 26 July 2025
Explore BasketAI Governance And Compliance Technology
This carefully selected group of stocks focuses on companies helping businesses navigate the complex world of AI regulations. As tensions rise between tech giants and regulators, these companies provide the essential tools and services organizations need to stay compliant and avoid costly penalties.
Published: 21 July 2025
Explore BasketAI Compliance Divergence: RegTech Solutions for EU Standards
This carefully selected group of stocks represents companies at the forefront of AI governance and compliance solutions. Our professional analysts have identified these opportunities emerging from the regulatory divide between tech giants like Microsoft and Meta, as businesses increasingly need specialized help to navigate complex AI rules.
Published: 20 July 2025
Explore BasketRegTech Automation Vendors
Get exposure to innovative companies using AI to tackle complex financial regulations. These carefully selected stocks represent leaders in automated compliance solutions - a growing necessity in today's highly regulated financial world.
Published: 17 June 2025
Explore BasketAI-Driven Drug Discovery
These groundbreaking companies are redefining pharmaceutical research with artificial intelligence. Each has been carefully selected by our analysts for their potential to develop life-saving drugs faster and more efficiently than traditional methods allow.
Published: 17 June 2025
Explore BasketPersonalized Medicine Portfolio
This collection features innovative companies revolutionizing healthcare by developing treatments tailored to individual genetic profiles. Carefully selected by our analysts, these stocks represent the cutting edge of precision medicine, where customized therapies aim to deliver more effective patient outcomes.
Published: 17 June 2025
Explore BasketNew Moon Portfolio
This collection represents the very beginning of the next technological cycle. These carefully selected companies are sowing the seeds of future industries, giving you early exposure to disruptive innovators poised for exponential growth as their technologies reshape our world.
Published: 17 June 2025
Explore BasketWhy You’ll Want to Watch This Stock
Growth from AI adoption
Investors may watch enterprise uptake and recurring revenue as signs of sustainable expansion, though growth can be uneven and valuation‑sensitive.
R&D and cash flow
Heavy spending on models and infrastructure can spur innovation but pressure margins and cash flow; monitor profitability trends closely.
Regulation and competition
Data rules and large competitor strategies shape the opportunity; regulatory changes or aggressive moves by incumbents can alter the outlook quickly.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
